Airway Medix S.A. erhält 2 Millionen EUR für die Entwicklung und Kommerzialisierung ihrer Projekte
Airway Medix hat zwei Investitionsvereinbarungen mit CoOpera, Kröner Medizintechnik und einer Schweizer Gruppe über bis zu 2 Millionen EUR unterzeichnet. Die Mittel fließen in die Entwicklung und Kommerzialisierung der drei patentierten Produkte des Unternehmens.
Volltext auf Englisch (Original)
Warsaw, November 16, 2023: Airway Medix has signed two Investment Agreements with CoOpera Finanzierungen Deutschland, Kröner Medizintechnik and a Swiss advisory and investment group. Partners will invest up to EUR 2 million, enabling the continuation of commercialization of innovative medical products on the EU, US, Asian and South American markets.
Three finished products, with international patents, focus on supporting patients' mechanical ventilation. Kröner Medizintechnik, CEO Peter Kröner, will be operationally and strategically involved in the company's development, covering production processes.
The partners, using their experience in the medical industry, granted the Company a EUR 900,000 loan, enabling it to complete negotiations and start business talks. The goal is to quickly commercialize products and develop synergies with partners' experience in the distribution of medical equipment.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative single-use devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Pressemitteilungen erscheinen so, wie Airway Medix S.A. sie herausgegeben hat. Produktaussagen folgen der Gebrauchsanweisung.
